A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 ``PembroRad'' trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreA phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 ``PembroRad'' trial.
Type de publicationJournal Article
Year of Publication2018
AuteursSun XShan, Sire C, Tao Y, Martin L, Alfonsi M, Prevost JBriac, Rives M, Lafond C, Tourani J-M, Biau J, Geoffrois L, Coutte A, Liem X, Vauleon E, Drouet F, Ramee J-F, Waksi G, Sinigaglia L, Auperin A, Bourhis J
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.15_suppl.6018